HIV 1 News and Research

RSS

Gilead Sciences seeks MAA in Europe for fixed-dose combination of Truvada and TMC278 for HIV-1 infection

Gilead Sciences, Inc. today announced that it has submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for marketing approval for the fixed-dose combination of Truvada® (emtricitabine and tenofovir disoproxil (as fumarate)) and Tibotec Pharmaceuticals' investigational non-nucleoside reverse transcriptase inhibitor TMC278 (rilpivirine (as hydrochloride)) for the treatment of HIV-1 infection in adults.

3 Sep 2010

NEJM publishes study on Xpert MTB/RIF test for rapid molecular detection of TB and rifampin resistance

Cepheid today announced that its Xpert® MTB/RIF test was the subject of a study published in the latest edition of the New England Journal of Medicine (NEJM), "Rapid Molecular Detection of Tuberculosis and Rifampin Resistance." The complete study is now available online (http://www.nejm.org) and will appear in the September 9 print edition.

3 Sep 2010

New TB diagnostic test effective in first large-scale field trial

Research assessing the effectiveness of a new diagnostic test for the detection of tuberculosis (TB) is featured in the Sept. 1 edition of the New England Journal of Medicine.

3 Sep 2010

New test detects TB faster, with more accuracy than current diagnostics, study says

A new molecular test for tuberculosis can diagnose the disease and detect a drug-resistant form of it in less than two hours and more accurately than current tests, according to the findings of a study published online in the New England Journal of Medicine on Wednesday, Reuters reports (Kelland, 9/1).

3 Sep 2010

AHF proposes innovative solution to resolve AIDS drug crisis in Florida

As the State of Florida grapples with a budget shortfall that is crippling its AIDS Drug Assistance Program and forcing the state to place more than 1,300 low-income Floridians on waiting lists to access lifesaving AIDS medications, AIDS Healthcare Foundation has proposed an innovative solution to state health officials and seven leading AIDS drug companies that would create a public/private partnership to resolve the drug crisis and get vulnerable Florida AIDS patients on to lifesaving antiretroviral treatment.

2 Sep 2010

Cannabis Science issues statement on marijuana study for post-surgery neuropathic pain

Cannabis Science, Inc., a pioneering U.S. biotech company developing pharmaceutical cannabis products, has issued a statement regarding a Canadian study on marijuana and intractable post-traumatic or post-surgery neuropathic pain that did not respond to conventional treatment.

2 Sep 2010

HHS Secretary announces grants for patient-centered outcome research

HHS Secretary Kathleen Sebelius today announced three sets of grants and cooperative agreements totaling nearly $17 million for patient-centered outcomes research (PCOR), or research that compares treatments and strategies to improve health outcomes for patients.

2 Sep 2010

HIV-infected children who receive HAART require revaccination: Researchers

HIV-infected children receiving highly active antiretroviral therapy may require revaccination to maintain immunity against preventable diseases. There remains no standard or official recommendation on revaccination of children receiving HAART, an effective intervention in reducing morbidity and mortality in HIV-infected children.

2 Sep 2010

Unitract Tuberculin syringe clears FDA 510k market clearance

Unilife Corporation, today announced that its Unitract Tuberculin (TB) Syringe has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA).

2 Sep 2010

Abbott RealTime HBV assay receives marketing approval from FDA

Abbott announced today it has received approval from the U.S. Food and Drug Administration to market the Abbott RealTime HBV assay for measuring viral load or the amount of hepatitis B virus in a patient's blood. It is the first and only approved test capable of automating HBV viral load testing from sample extraction to final results.

2 Sep 2010

U.N. Secretary-General, UNAIDS Executive Director highlight role NGOs can play in achieving MDGs

During the 63rd U.N. Department of Public Information/NGO Conference on Monday in Melbourne, Australia, U.N. Secretary-General Ban Ki-moon "call[ed] on delegates to do more to save the lives of mothers and babies," the Australian Associated Press/Sydney Morning Herald reports (Alexander/Rose, 8/30).

2 Sep 2010

Also in Global Health News: China's first HIV discrimination case; Congo mass rape; S. Sudan flooding; Kenya's population growth; Family planning in the Philippines

"A municipal court in central China has accepted the country's first lawsuit alleging work discrimination because of HIV status, state media reported Tuesday," the Associated Press reports (8/31). "The lawsuit alleges city officials denied the plaintiff, a recent college graduate, a teaching job after a medical screening revealed he had HIV, the virus that causes AIDS," Agence-France-Presse reports (8/31).

2 Sep 2010

World becoming numb to HIV/AIDS: UNAIDS executive director

HIV infection is on the rise but there is potential to control the upsurge of infections with effective measures only if there are adequate funds. According to UNAIDS executive director Michel Sidibe the world has become numb to the fact that 7,400 people are being infected with AIDS every day and funds to combat it are not pouring in as they should. Since 2001, the number of newly infected people has fallen by 17 per cent a year - but there are still 2.7 million new cases each year.

1 Sep 2010

Greater clarity on legal implications of testing incapacitated patients for blood-borne viruses needed

Anaesthetists are calling for greater clarity on the legal implications of testing incapacitated patients for blood-borne viruses, after a survey found that this is often done following staff needlestick injuries, in possible breach of UK legislation.

31 Aug 2010

MGH scientists develop new microfluidic tool for accurate isolation of neutrophils

A team led by Massachusetts General Hospital (MGH) scientists has developed a new microfluidic tool for quickly and accurately isolating neutrophils - the most abundant type of white blood cell - from small blood samples, an accomplishment that could provide information essential to better understanding the immune system's response to traumatic injury. The system, described in a Nature Medicine paper that received advance online release, also can be adapted to isolate almost any type of cell.

31 Aug 2010

AHF online community grows to 100,000

AIDS Healthcare Foundation (AHF), the largest global AIDS organization, today announced that its online community has grown to 100,000 people, including 64,643 Facebook followers and 32,690 members of its website e-community. The group credits its rapidly growing online community with significantly bolstering its recent advocacy efforts targeting heavy-hitters such as President Obama, Speaker of the House Nancy Pelosi and drug giant Bristol-Myers Squibb (BMS).

31 Aug 2010

U.N.-NGO conference on MDGs kicks off in Australia

Ahead of next month's U.N. Summit in New York, a joint U.N.-NGO conference tracking the world's progress toward reaching the U.N. Millennium Development Goals (MDGs) kicked off in Melbourne, Australia, on Monday, ABC News reports (8/30).

30 Aug 2010

Opinions: MDG progress; Drug patents; Aid for scientific research; Avoiding food crises; Hunger in India; U.S. commitments to PEPFAR, Global Fund

"Between the catastrophes of the Haiti earthquake and the Pakistan floods, there was actually some good news this spring on the global health front, which offers hope that the United Nations' ambitious Millennium Development Goals might not be at a standstill. Though a great deal remains to be done, all of us are living longer, fewer mothers are dying in childbirth, and fewer children are dying before school age," Eli Adashi, professor of medical science at Brown University, writes in Boston Globe editorial.

30 Aug 2010

Also in Global Health News: GM mosquitoes; Iodine deficiency in Nepal; South African health workers strike; Novartis to build vaccine plant in Brazil; Population control in Niger

Malaysia is still "considering releasing" up to 3,000 mosquitoes that are genetically modified to "combat dengue fever, in a landmark field trial that has come in for criticism from environmentalists," Agence France-Presse reports. The insects are modified "so that their offspring quickly die," which researchers hope will cull the population and lessen the risk of dengue.

30 Aug 2010

Revolutions Medical seeks due recognition for RevVac vacuum operated auto retractable safety syringe

Revolutions Medical Corporation has notified the MDEA that there had been an error in awarding the Free Vac syringe the 2010 Medical Design Excellence Award when in fact Free Vac misrepresented ownership of the syringe. The syringe was actually Revolutions Medical Corporation's RevVac auto retractable safety syringe.

30 Aug 2010

HIV 1 News and Research

Gilead Sciences seeks MAA in Europe for fixed-dose combination of Truvada and TMC278 for HIV-1 infection

NEJM publishes study on Xpert MTB/RIF test for rapid molecular detection of TB and rifampin resistance

New TB diagnostic test effective in first large-scale field trial

New test detects TB faster, with more accuracy than current diagnostics, study says

AHF proposes innovative solution to resolve AIDS drug crisis in Florida

Cannabis Science issues statement on marijuana study for post-surgery neuropathic pain

HHS Secretary announces grants for patient-centered outcome research

HIV-infected children who receive HAART require revaccination: Researchers

Unitract Tuberculin syringe clears FDA 510k market clearance

Abbott RealTime HBV assay receives marketing approval from FDA

U.N. Secretary-General, UNAIDS Executive Director highlight role NGOs can play in achieving MDGs

Also in Global Health News: China's first HIV discrimination case; Congo mass rape; S. Sudan flooding; Kenya's population growth; Family planning in the Philippines

World becoming numb to HIV/AIDS: UNAIDS executive director

Greater clarity on legal implications of testing incapacitated patients for blood-borne viruses needed

MGH scientists develop new microfluidic tool for accurate isolation of neutrophils

AHF online community grows to 100,000

U.N.-NGO conference on MDGs kicks off in Australia

Opinions: MDG progress; Drug patents; Aid for scientific research; Avoiding food crises; Hunger in India; U.S. commitments to PEPFAR, Global Fund

Also in Global Health News: GM mosquitoes; Iodine deficiency in Nepal; South African health workers strike; Novartis to build vaccine plant in Brazil; Population control in Niger

Revolutions Medical seeks due recognition for RevVac vacuum operated auto retractable safety syringe

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Latest News